A Phase I, Single-Centre, Double-Blind, Randomized, Placebo-Controlled Clinical Trial To Determine Urinary Xylose Cut-Off Point For The Diagnosis Of Hypolactasia, After A Single Dose Of Gaxilose in Children Between 5 – 11 Years Of Age. - VPH-GXL-2022-511
Latest Information Update: 23 Apr 2026
At a glance
- Drugs Gaxilose (Primary)
- Indications Digestive system disorders
- Focus Pharmacokinetics
- Sponsors Venter Pharma
Most Recent Events
- 23 Apr 2026 New trial record